STSS
STSS company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
5 articles
Price performance
Recent trading
Newsroom
Latest STSS coverage

Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily
[ad_1] NEW YORK, NY – (NewMediaWire) – September 22, 2023 – Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily providing insights into the Company's innovative drug delivery technologies. Hayes discussed Sharps' vision for the pharmaceutical and healthcar

Sharps Technology Appoints Justin Page as Vice President of Technical Operations
Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations.

Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces the first shipments of product from its wholly owned manufacturing facility in Hungary to Nephron Pharmaceuticals to advance the Company's first commercial operatio

Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products
Sharps Technology, Inc. announces they have commenced manufacturing of their much-needed ultra-low waste smart safety syringe products in their European operation in Hungary.

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”), announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as Nephron prepares to launch the Company's InjectEZ component of expansion.